BIND Therapeutics, Inc. is a clinical-stage nanomedicine company headquartered in Cambridge, Massachusetts. The company specializes in developing targeted and programmable therapeutics using its proprietary platform to treat various diseases.
Subscribe to see BIND Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
BIND Therapeutics is a biotechnology company headquartered in Cambridge, United States. It has raised at least $56M across the 4 funding rounds on record. Its most recent funding round, Venture Round, raised $25M in October 2011. Xcout tracks 4 named people at BIND Therapeutics, including Strange Melissa (Founding CFO).
As of 16 November 2026. Source: Xcout Intel.
At least $56M raised across the 4 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Venture Round | $25M | 1 named | |
| Series C | $12M | — | |
| Series B | $16M | — | |
| Series A | $3M | 3 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A funding-flow diagram of the 4 named investors across 2 rounds: who backed which round, who led it, and who came back for the next one.
Sign in to see it, or subscribe for the full funding history →
A few of BIND Therapeutics's closest competitors — see the full list of competitors and alternatives →
Violet Therapeutics, Inc. is a therapeutics company headquartered in Cambridge, Massachusetts, utilizing novel proprietary platforms for drug development.
Exo Therapeutics is a small molecule drug discovery and development biotechnology company headquartered in Cambridge, Massachusetts. The company utilizes a pioneering proprietary technology platform to unlock and address notoriously intractable pharmaceutical and disease targets.
Vibrant Therapeutics is a clinical-stage biotechnology company headquartered in Cambridge, Massachusetts, with operations in China. Founded in July 2019, the firm focuses on revolutionizing protein drug discovery and developing next-generation prodrugs with precise targeting.
Xanadu Bio, Inc. is a biotechnology company that develops next-generation polymer nanoparticle delivery platforms for mRNA and other nucleic acid-based therapies. Utilizing its proprietary poly(amine-co-ester) (PACE) polymer technology, the company creates tunable, organ-specific treatments for oncology and immunology, as well as intranasal vaccines for viral respiratory pathogens.
Ratio Therapeutics is a clinical-stage pharmaceutical company headquartered in Boston, Massachusetts. The company employs a suite of innovative technologies for the discovery and early clinical development of targeted radiopharmaceuticals.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about BIND Therapeutics? Suggest a correction · Work at BIND Therapeutics? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.